Mark Danna is the Director of U.S. Market Access and Contract Strategy at Bayer Pharmaceuticals, where they utilize over 20 years of experience in healthcare, technology, and consumer goods to develop and implement market strategies. Previously, Mark held significant positions at BD, Johnson & Johnson, and Lucent Technologies, where they negotiated agreements and led successful teams. They earned a Bachelor's degree in Finance from The College of New Jersey and a Master’s degree in Entrepreneurial Finance from Babson College, and have completed a leadership development program at Lucent Technologies. Mark specializes in market development, contract strategy, and financial modeling.
This person is not in the org chart
This person is not in any teams
This person is not in any offices